Robert K. DeLong

1.7k total citations
56 papers, 1.2k citations indexed

About

Robert K. DeLong is a scholar working on Molecular Biology, Biomedical Engineering and Materials Chemistry. According to data from OpenAlex, Robert K. DeLong has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 7 papers in Biomedical Engineering and 6 papers in Materials Chemistry. Recurrent topics in Robert K. DeLong's work include Advanced biosensing and bioanalysis techniques (31 papers), RNA Interference and Gene Delivery (30 papers) and DNA and Nucleic Acid Chemistry (12 papers). Robert K. DeLong is often cited by papers focused on Advanced biosensing and bioanalysis techniques (31 papers), RNA Interference and Gene Delivery (30 papers) and DNA and Nucleic Acid Chemistry (12 papers). Robert K. DeLong collaborates with scholars based in United States, Belgium and India. Robert K. DeLong's co-authors include Michael H. Fisher, R. L. Juliano, Rudolph L. Juliano, Suresh K. Alahari, Hyun Min Kang, Adam K. Wanekaya, Arno Nolting, K. Ghosh, Nicholas M. Dean and M. H. FISHER and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Robert K. DeLong

55 papers receiving 1.2k citations

Peers

Countries citing papers authored by Robert K. DeLong

Since Specialization

Citations

This map shows the geographic impact of Robert K. DeLong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert K. DeLong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert K. DeLong more than expected).

Fields of papers citing papers by Robert K. DeLong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert K. DeLong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert K. DeLong. The network helps show where Robert K. DeLong may publish in the future.

Co-authorship network of co-authors of Robert K. DeLong

This figure shows the co-authorship network connecting the top 25 collaborators of Robert K. DeLong. A scholar is included among the top collaborators of Robert K. DeLong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert K. DeLong. Robert K. DeLong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Progress and Promise of RNA Medicine─An Arsenal of Targeted Treatments 2022 ·Journal of Medicinal Chemistry ·Janet M. Sasso, (unknown), Rumiana Tenchov, Ruchira S. Datta, Matthew T. Basel, Robert K. DeLong, Qiongqiong Angela Zhou	74
2	Enzyme Nanoscale Interactions with Manganese Zinc Sulfide Give Insight into Potential Antiviral Mechanisms and SARS-CoV-2 Inhibition 2022 ·ACS Pharmacology & Translational Science ·Robert K. DeLong, (unknown), (unknown), (unknown), Ryan Swanson, Tej B. Shrestha, Natasha N. Gaudreault	2
3	Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates 2021 ·Pharmaceuticals ·(unknown), Majid Jaberi‐Douraki, (unknown), (unknown), (unknown), Xuan Xu, (unknown), Natasha N. Gaudreault, Robert K. DeLong	2
4	Ushering in a new era of RNA-based therapies 2021 ·Communications Biology ·Robert K. DeLong	3
5	Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interference 2020 ·PLoS ONE ·(unknown), (unknown), Baolin Wang, Vaibhav Murthy, Yuntao Zhang, Robert K. DeLong	5
6	Translating Nanomedicine to Comparative Oncology—the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Robert K. DeLong, Yi‐Hsien Cheng, (unknown), Zhoumeng Lin, (unknown), (unknown), (unknown), (unknown), Mary Lynn Higginbotham	8
7	Comparative functional dynamics studies on the enzyme nano-bio interface 2018 ·International Journal of Nanomedicine ·(unknown), Jeffrey Comer, (unknown), (unknown), Vaibhav Murthy, Meghana Ramani, (unknown), (unknown), Seong‐O Choi, Robert K. DeLong	7
8	A High-Throughput Screening Assay for the Functional Delivery of Splice-Switching Oligonucleotides in Human Melanoma Cells 2015 ·Methods in molecular biology ·(unknown), Robert K. DeLong	2
9	Tipping the Proteome with Gene-Based Vaccines: Weighing in on the Role of Nanomaterials 2012 ·SHILAP Revista de lepidopterología ·(unknown), Michael Craig, Adam K. Wanekaya, Lifeng Dong, K. Ghosh, J. Joshua Smith, Robert K. DeLong	2
10	Effects of Nanomaterials on Luciferase with Significant Protection and Increased Enzyme Activity Observed for Zinc Oxide Nanomaterials 2011 ·Journal of Nanoscience and Nanotechnology ·(unknown), (unknown), Krishna Ghosh, Lauren A. Mitchell, (unknown), Benjamin Jacobs, (unknown), (unknown), Adam K. Wanekaya, Garry Glaspell, Robert K. DeLong	7
11	Characterization and performance of nucleic acid nanoparticles combined with protamine and gold 2009 ·Biomaterials ·Robert K. DeLong, (unknown), (unknown), (unknown), (unknown), Jie Zhang, Michael Craig, Richard C. Garrad, Anthony J. Hickey, Eric M. Engstrom	40
12	Challenges and Potential for RNA Nanoparticles (RNPs) 2009 ·Journal of Biomedical Nanotechnology ·David Davis, (unknown), (unknown), Karl Grozinger, (unknown), (unknown), (unknown), Robert K. DeLong	5
13	Towards biosensors based on conducting polymer nanowires 2008 ·Analytical and Bioanalytical Chemistry ·(unknown), Michael Craig, Robert K. DeLong, Kartik Ghosh, Adam K. Wanekaya	35
14	R4 Peptide-pDNA Nanoparticle Coated HepB Vaccine Microparticles: Sedimentation, Partitioning, and Spray Freeze Dry Bioprocesses 2006 ·Journal of Nanoscience and Nanotechnology ·(unknown), Achim Werner, Robert K. DeLong	5
15	Novel cationic amphiphiles as delivery agents for antisense oligonucleotides 1999 ·Nucleic Acids Research ·Robert K. DeLong, Hah Young Yoo, Suresh K. Alahari, M. H. FISHER, Sarah M. Short, (unknown), Ryszard Kole, Václav Janout, (unknown), R. L. Juliano	24
16	Interactions between single-stranded DNA binding protein and oligonucleotide analogs with different backbone chemistries 1997 ·Journal of Molecular Recognition ·(unknown), Robert K. DeLong, Eric Wickstrom, (unknown), (unknown), Marvin H. Caruthers, R. L. Juliano	16
17	Comparative Pharmacokinetics, Tissue Distribution, and Tumor Accumulation of Phosphorothioate, Phosphorodithioate, and Methylphosphonate Oligonucleotides in Nude Mice 1997 ·Antisense and Nucleic Acid Drug Development ·Robert K. DeLong, Arno Nolting, M. H. FISHER, (unknown), Eric Wickstrom, (unknown), (unknown), M. H. CARUTHERS, R. L. Juliano	42
18	Hepatic Distribution and Clearance of Antisense Oligonucleotides in the Isolated Perfused Rat Liver 1997 ·Pharmaceutical Research ·Arno Nolting, Robert K. DeLong, Michael H. Fisher, Eric Wickstrom, Gary M. Pollack, Rudolph L. Juliano, Kim L. R. Brouwer	18
19	Inhibition of Human Collagenase Activity by Antisense Oligonucleoside Methylphosphonates 1996 ·Antisense and Nucleic Acid Drug Development ·Robert K. DeLong, Paul S. Miller	8
20	Triplex Formation by a Psoralen-Conjugated Oligodeoxyribonucleotide Containing the Base Analog 8-Oxo-Adenine 1996 ·Nucleic Acids Research ·Paul S. Miller, (unknown), (unknown), (unknown), Robert K. DeLong	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact